Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study

      Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study

      Garima18 May 2019 9:30 AM IST
      Abrocitinib, which belongs to a class of drugs known as JAK inhibitors, which block inflammation-causing enzymes, known as Janus kinases, achieved...
      Morgan Stanley to invest Rs 145 crore in Manipal Health Enterprise

      Morgan Stanley to invest Rs 145 crore in Manipal Health Enterprise

      Garima17 May 2019 9:45 AM IST
      Manipal Health Enterprises Pvt Ltd is backed by private equity majors including Singapore's Temasek and TPG.Mumbai: Morgan Stanley India...
      Sun pharma, Dr Reddys, others deny allegations of price fixing in US

      Sun pharma, Dr Reddys, others deny allegations of price fixing in US

      Garima16 May 2019 9:35 AM IST
      In separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
      Japan: Novartis gets Government nod for cancer treatment Kymriah at cost of $305800

      Japan: Novartis gets Government nod for cancer treatment Kymriah at cost of $305800

      Garima15 May 2019 9:15 AM IST
      Kymriah works by removing disease-fighting T-cells from individual patients, modifying them to attack cancer, and then re-infusing them back into the...
      Jury: Monsanto to pay $2 billion in weed killer cancer case

      Jury: Monsanto to pay $2 billion in weed killer cancer case

      Garima14 May 2019 9:00 AM IST
      SAN FRANCISCO: A jury on Monday ordered agribusiness giant Monsanto Co. to pay a combined $2.055 billion to a couple claiming that the company's...
      As e-pharmacies battle regulatory issues, Netmeds reported to be in talks to raise funds over Rs 698 crore

      As e-pharmacies battle regulatory issues, Netmeds reported to be in talks to raise funds over Rs 698 crore

      Garima12 May 2019 1:37 PM IST
      New Delhi: Despite regulatory objections being raised over the practice of online pharmacy, the faith of the investment community in the future of...
      Strides Pharma reports Q4 profit after tax at Rs 43.81 crore

      Strides Pharma reports Q4 profit after tax at Rs 43.81 crore

      Garima12 May 2019 10:00 AM IST
      Moving into the new financial year, Strides Pharma Science's emerging market and institutional business will get the highest attention and...
      Pfizer acquires clinical-stage Biotech Therachon for $810 million

      Pfizer acquires clinical-stage Biotech Therachon for $810 million

      Garima12 May 2019 9:45 AM IST
      NEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
      GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore

      GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore

      Garima11 May 2019 9:35 AM IST
      In a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10...
      Indivior signs deal to sell schizophrenia drug Perseris in Canada

      Indivior signs deal to sell schizophrenia drug Perseris in Canada

      Garima11 May 2019 9:10 AM IST
      Perseris, launched in the United States in February, is approved by the FDA for the treatment of schizophrenia in adults.U.S: British drugmaker...
      HealthKart raises USD 25 million from Sofina to expand offline network

      HealthKart raises USD 25 million from Sofina to expand offline network

      Garima10 May 2019 10:05 AM IST
      HealthKart will use the funds to expand its offline store network, develop additional direct-to-consumer nutrition brands and strengthen its vertical...
      Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada

      Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada

      Garima10 May 2019 9:30 AM IST
      Synolis VA (Visco-Antalgic) is the intra-articular injection product for osteoarthritis with a unique combination of Hyaluronic Acid and high...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok